Using PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?

by Simeng Li, Volga Tarlac, Justin R. Hamilton
Published 2019-11-01

Differential Signaling by Protease-Activated Receptors: Implications for Therapeutic Targeting

by Tejminder S. Sidhu, Shauna L. French, Justin R. Hamilton
Published 2014-04-01

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platel...

by Shauna L French, Antonia C Paramitha, Mitchell J Moon, Ross A Dickins, Justin R Hamilton
Published 2016-01-01

Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population

by Dian Ningtyas, Russell J. Thomson, Volga Tarlac, Shivashankar H. Nagaraj, Shivashankar H. Nagaraj, Wendy Hoy, John D. Mathews, John D. Mathews, Simon J. Foote, Elizabeth E. Gardiner, Justin R. Hamilton, Brendan J. McMorran
Published 2020-04-01